Home » Topics » Disease categories and therapies » Endocrine/metabolic

Endocrine/metabolic
RSS

SomatoKine progresses to phase II for a new disease indication

July 22, 1998

Kos files European marketing application for Niaspan and begins clinical trials with Nicostatin

July 22, 1998

Yoshitomi prepares agents for hyperuricemia and gout

July 21, 1998

Arylureas and arylmethylcarbamoyl derivatives as ACAT inhibitors

July 21, 1998

Increased sexual activity in Muse-treated men does not mean increased risk of CV side effects

July 21, 1998

Generex submits IND for Oralin in Canada

July 21, 1998

Sanwa Kagaku licenses Bayer antidiabetic agent for Japanese development

July 20, 1998

New treatment for male hypogonadism introduced in Germany

July 20, 1998

Novel compounds described by Japan Energy for lipid disorders

July 20, 1998

LY-117018 is fully protective during the later slow phase of bone loss

July 20, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 6, 2026.
CROI 2026 highlights depression and cognitive vulnerability in HIV
BioWorld
The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
University of Southern California reports new MAPT aggregation inhibitors
BioWorld Science
The University of Southern California has identified (2-oxo-2H-chromen-3-yl) scaffold-based carboxamide analogues acting as potent microtubule-associated protein...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...